Announced Sat, 8 Aug · 15:10 IST
Board Meeting on Aug 13 2026 to Approve Q1 FY27 Results
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.4%1-day move
₹412.60
prior close
₹416.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.7-0.1-0.7-0.7-2.4-3.0+0.3-3.8+0.1-2.2-6.7-6.0——
Up moveDown movePending
AI summary
Panacea Biotec's Board will meet on August 13, 2026 in New Delhi to consider and approve the Standalone and Consolidated Unaudited Financial Results for the quarter ended June 30, 2026 (Q1 FY27). The trading window stays closed for designated persons and their immediate relatives from July 1 to August 15, 2026 per insider trading rules.
Likely market impact
Routine board meeting notice. Watch for Q1 FY27 results on Aug 13 as the numbers may move the stock.